Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Debt Ratio (2016 - 2023)

Arcadia Biosciences' Debt Ratio history spans 10 years, with the latest figure at 0.0 for Q1 2023.

  • For Q1 2023, Debt Ratio fell 72.26% year-over-year to 0.0; the TTM value through Mar 2023 reached 0.0, down 72.26%, while the annual FY2022 figure was 0.0, 13.89% up from the prior year.
  • Debt Ratio reached 0.0 in Q1 2023 per RKDA's latest filing, down from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.08 in Q3 2020 to a low of 0.0 in Q1 2023.
  • Average Debt Ratio over 5 years is 0.02, with a median of 0.0 recorded in 2022.
  • Peak YoY movement for Debt Ratio: surged 9660.11% in 2020, then tumbled 97.85% in 2021.
  • A 5-year view of Debt Ratio shows it stood at 0.0 in 2019, then surged by 1399.96% to 0.07 in 2020, then crashed by 97.85% to 0.0 in 2021, then increased by 13.89% to 0.0 in 2022, then plummeted by 70.28% to 0.0 in 2023.
  • Per Business Quant, the three most recent readings for RKDA's Debt Ratio are 0.0 (Q1 2023), 0.0 (Q4 2022), and 0.0 (Q3 2022).